Real-world experience of teriflunomide in relapsing multiple sclerosis: paramagnetic rim lesions may play a role

ConclusionTeriflunomide is effective in reducing ARR in Chinese patients with RRMS. Patients with less PRL burden, less frequent relapses, and relatively older age are likely to benefit more from teriflunomide, indicating that PRL might be a valuable measurement to inform clinical treatment decision.
Source: Frontiers in Immunology - Category: Allergy & Immunology Source Type: research